Modern Healthcare reports on a growing wave of PBM consolidation as smaller organizations seek the scale and resources needed to compete in an ever-changing market. This article examines transactions involving companies such as MedImpact and LucyRx and what they signal about the future of prescription care.
The simple reality is that scale helps innovative ideas reach more people. For LucyRx, the story demonstrates why clients are looking for partners that combine clear incentives, modern technology, and accountable prescription care while helping them manage costs with greater confidence.
Share